Testing effectiveness (Phase 2)Study completedNCT00144677
What this trial is testing
Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation
Who this might be right for
Acute Myelogenous LeukemiaGraft Versus Host DiseaseAcute Lymphoblastic Leukemia+4 more
Dana-Farber Cancer Institute 30